Myelodysplastic syndromes (MDS) are clonal disorders of the hematopoietic stem cell characterized by ineffective hematopoiesis leading to peripheral cytopenias. Different …

A combination of PR-1 and WT-1 peptides has been tested by Rezvani et al. in a Phase I safety clinical trial for eight HLA-A*0201-positive patients with low-risk myeloid malignancies. [39,58] …

2023年11月24日 · Stability and optimal control of a cytokine-enhanced general HIV infection model with antibody immune response and CTLs immune response. November 07, 2023 [ …

Other active immunization regimens, such as activation of CTLs for many different types of cancer, have been exclusively and extensively used without much success so far, but there is …